AH Partridge

Publications by Year

Research Areas

Breast Cancer Treatment Studies, Cancer Risks and Factors, Reproductive Biology and Fertility, BRCA gene mutations in cancer, Cancer survivorship and care

Most-Cited Works

• → Patient adherence and persistence with oral anticancer treatment(2009)561 cited
• → Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study(2008)173 cited
• → Menopausal-type symptoms in young breast cancer survivors(2006)94 cited
• → Abstract S1-04: A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)(2013)36 cited
• → Abstract GS4-01: Pooled analysis of five randomized trials investigating temporary ovarian suppression with gonadotropin-releasing hormone analogs during chemotherapy as a strategy to preserve ovarian function and fertility in premenopausal early breast cancer patients(2018)13 cited
• → A survey on physicians’ knowledge, practice and attitudes on fertility and pregnancy issues in young breast cancer patients(2017)7 cited
• → 1814O Breastfeeding in women with hormone receptor-positive breast cancer who conceived after temporary interruption of endocrine therapy: Results from the POSITIVE trial(2024)6 cited
• → Abstract OT1-01-06: POSITIVE: A study evaluating Pregnancy, disease outcome and safety of interrupting endocrine therapy for premenopausal women with endocrine responsIVE breast cancer who desire pregnancy (IBCSG 48-14/BIG 8-13)(2019)6 cited
• → Abstract OT3-02-01: POSITIVE: A study evaluating pregnancy and disease outcome and safety of interrupting endocrine therapy for young women with endocrine-responsive breast cancer who desire pregnancy (IBCSG 48-14/BIG 8-13)(2017)5 cited
• → Predictive and prognostic value of B-cell gene-expression signatures and B-cell receptor (BCR) repertoire in HER2+ breast cancer: A correlative analysis of the CALGB 40601 clinical trial (Alliance)(2019)5 cited